KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Equity (2016 - 2025)

Eli Lilly's Return on Equity history spans 16 years, with the latest figure at 0.82% for Q4 2025.

  • For Q4 2025, Return on Equity fell 64.0% year-over-year to 0.82%; the TTM value through Dec 2025 reached 0.82%, down 64.0%, while the annual FY2025 figure was 1.01%, 3.0% up from the prior year.
  • Return on Equity reached 0.82% in Q4 2025 per LLY's latest filing, down from 1.67% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 39.21% in Q2 2024 to a low of 7.71% in Q2 2025.
  • Average Return on Equity over 5 years is 4.25%, with a median of 1.43% recorded in 2023.
  • Peak YoY movement for Return on Equity: skyrocketed 4329bps in 2024, then crashed -4691bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 14.43% in 2021, then plummeted by -136bps to 5.16% in 2022, then skyrocketed by 127bps to 1.39% in 2023, then increased by 5bps to 1.46% in 2024, then crashed by -44bps to 0.82% in 2025.
  • Per Business Quant, the three most recent readings for LLY's Return on Equity are 0.82% (Q4 2025), 1.67% (Q3 2025), and 7.71% (Q2 2025).